HURA · Forms 3, 4, 5
Insider trades at TuHURA Biosciences, Inc./NV
No open-market insider buys or sells at TuHURA Biosciences, Inc./NV in the last 90 days; 10 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for TuHURA Biosciences, Inc./NV (HURA) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Most recent insider filings
No Form 3, 4 or 5 filings for TuHURA Biosciences, Inc./NV in the last 90 days. The latest ones on EDGAR:
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| James A. Bianco | Chief Executive Officer | Gift | 150,000 | Form 4 | |||
| Craig Tendler | Director | Options or other derivatives | Form 4 | ||||
| George K Ng | Director | Options or other derivatives | Form 4 | ||||
| James S J Manuso | Director | Options or other derivatives | Form 4 | ||||
| Alan List | Director | Options or other derivatives | Form 4 | ||||
| Robert E. Hoffman | Director | Options or other derivatives | Form 4 | ||||
| Dan Dearborn | Chief Financial Officer | Options or other derivatives | Form 4 | ||||
| James A. Bianco | Chief Executive Officer | Options or other derivatives | Form 4 | ||||
| Dan Dearborn | Chief Financial Officer | Options or other derivatives | Form 4 | ||||
| James A. Bianco | Chief Executive Officer | Options or other derivatives | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.